Literature DB >> 23019412

Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma.

Karolin H Nord1, Kajsa Paulsson, Srinivas Veerla, Johan Wejde, Otte Brosjö, Nils Mandahl, Fredrik Mertens.   

Abstract

Inflammatory leiomyosarcoma (ILMS) is a soft tissue tumor that morphologically resembles conventional leiomyosarcoma (LMS) admixed with a prominent inflammatory infiltrate. Genetic data on ILMS are still limited but have suggested that this entity is characterized by hyperhaploidy (24-34 chromosomes). This low chromosome number is otherwise uncommon in neoplasia and has been found only in 0.2% to 0.3% of cytogenetically investigated tumors. Here, three ILMS were investigated using cytogenetic, single-nucleotide polymorphism (SNP) array, and global gene expression analyses. All cases displayed a hyperhaploid origin. Combined with previously reported cases, hyperhaploidy has been found in six of seven cytogenetically investigated ILMS. The copy number distribution of individual chromosomes is clearly nonrandom; the hyperhaploid clones of all six cases displayed disomy for chromosomes 5 and 20, and two copies of chromosomes 18, 21, and 22 were also common. All chromosomes identified as disomic showed a biparental origin by SNP array analysis; whether this is of pathogenetic importance is not known. Compared with conventional LMS, ILMS had a distinct gene expression signature. Furthermore, the number of chromosome copies correlated well with gene expression levels; disomic chromosomes showed higher gene expression levels than monosomic chromosomes, a finding that has not previously been reported for hyperhaploid tumors. Taken together, our findings suggest that disomy for some chromosomes, notably 5 and 20, as well as distorted gene expression achieved through massive loss of other chromosomes are essential features of ILMS.

Entities:  

Mesh:

Year:  2012        PMID: 23019412      PMCID: PMC3459276          DOI: 10.1593/neo.12930

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  17 in total

1.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

2.  Computational and experimental identification of novel human imprinted genes.

Authors:  Philippe P Luedi; Fred S Dietrich; Jennifer R Weidman; Jason M Bosko; Randy L Jirtle; Alexander J Hartemink
Journal:  Genome Res       Date:  2007-11-30       Impact factor: 9.043

3.  Widespread monoallelic expression on human autosomes.

Authors:  Alexander Gimelbrant; John N Hutchinson; Benjamin R Thompson; Andrew Chess
Journal:  Science       Date:  2007-11-16       Impact factor: 47.728

Review 4.  Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects.

Authors:  Reiner A Veitia; Samuel Bottani; James A Birchler
Journal:  Trends Genet       Date:  2008-06-26       Impact factor: 11.639

Review 5.  Gene and genome duplications: the impact of dosage-sensitivity on the fate of nuclear genes.

Authors:  Patrick P Edger; J Chris Pires
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

Review 6.  Inflammatory leiomyosarcoma may be characterized by specific near-haploid chromosome changes.

Authors:  P Dal Cin; R Sciot; C D Fletcher; I Samson; R De Vos; N Mandahl; H Willén; O Larsson; H Van den Berghe
Journal:  J Pathol       Date:  1998-05       Impact factor: 7.996

7.  New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.

Authors:  Laure Gibault; Gaëlle Pérot; Frédéric Chibon; Sarah Bonnin; Pauline Lagarde; Philippe Terrier; Jean-Michel Coindre; Alain Aurias
Journal:  J Pathol       Date:  2010-10-25       Impact factor: 7.996

8.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

9.  Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma.

Authors:  W Merchant; E Calonje; C D Fletcher
Journal:  Histopathology       Date:  1995-12       Impact factor: 5.087

10.  Clonal evolution through loss of chromosomes and subsequent polyploidization in chondrosarcoma.

Authors:  Linda Olsson; Kajsa Paulsson; Judith V M G Bovée; Karolin H Nord
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

View more
  8 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 2.  WHO Pathology: Highlights of the 2020 Sarcoma Update.

Authors:  Inga-Marie Schaefer; Alessandro Gronchi
Journal:  Surg Oncol Clin N Am       Date:  2022-05-31       Impact factor: 2.402

3.  Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature.

Authors:  Elsa Arbajian; Jan Köster; Fredrik Vult von Steyern; Fredrik Mertens
Journal:  Mod Pathol       Date:  2017-09-08       Impact factor: 7.842

4.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

5.  Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.

Authors:  Kristina Karrman; Anders Castor; Mikael Behrendtz; Erik Forestier; Linda Olsson; Mats Ehinger; Andrea Biloglav; Thoas Fioretos; Kajsa Paulsson; Bertil Johansson
Journal:  J Hematol Oncol       Date:  2015-04-24       Impact factor: 17.388

6.  Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report.

Authors:  Alberto Bongiovanni; Nada Riva; Marianna Ricci; Laura Mercatali; Chiara Liverani; Federico La Manna; Alessandro De Vita; Davide Cavaliere; Federica Pieri; Devil Oboldi; Giorgio Maria Verdecchia; Dino Amadori; Toni Ibrahim
Journal:  BMC Cancer       Date:  2015-12-22       Impact factor: 4.430

7.  Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.

Authors:  Madina Sukhanova; Farres Obeidin; Lukas Streich; Borislav A Alexiev
Journal:  Genes Chromosomes Cancer       Date:  2022-06-30       Impact factor: 4.263

8.  Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.

Authors:  Setareh Safavi; Linda Olsson; Andrea Biloglav; Srinivas Veerla; Molly Blendberg; Johnbosco Tayebwa; Mikael Behrendtz; Anders Castor; Markus Hansson; Bertil Johansson; Kajsa Paulsson
Journal:  Oncotarget       Date:  2015-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.